Lee et al. developed a DNA polyaptamer hydrogel (PAH) that can be cut by Cas9/sgRNA for the programmed release of a PD-1 DNA aptamer that can block the interaction between the PD-1 cell-surface and the PD-L1 tumor cell-surface. The gene discussed is CD274; the disease is neoplasm.